QSS
SNDX icon

Quantitative Systematic Strategies’s Syndax Pharmaceuticals SNDX Stock Holding History

Quantitative Systematic Strategies’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,221
Closed -$227K – 314
2021
Q2 		$227K Sell
13,221
-20,948
-61% -$384K 0.08% 400
2021
Q1 		$764K Sell
34,169
-8,988
-21% -$203K 0.12% 287
2020
Q4 		$960K Buy
43,157
+29,351
+213% +$609K 0.14% 250
2020
Q3 		$204K Buy
+13,806
New +$210K 0.04% 522

Other funds holding SNDX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Quantitative Systematic Strategies's SNDX Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Syndax Pharmaceuticals (SNDX) in Q3 2021, closing a stake of 13,221 shares — an estimated $227K sold.

Quantitative Systematic Strategies first reported a position in SNDX in Q3 2020 and held it in 4 quarters. The position peaked at $960K in Q4 2020. 123 funds tracked by Wall St. Rank hold SNDX as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Syndax Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 13,221 Syndax Pharmaceuticals shares in Q3 2021, an estimated $227K.
  • Quantitative Systematic Strategies first reported a position in Syndax Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • Quantitative Systematic Strategies's Syndax Pharmaceuticals position peaked at $960K in Q4 2020.
  • 123 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.